Gene · 134
Papers2,244
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,244
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Short Sleep Duration and Erectile Dysfunction: A Review of the Literature. | Nat Sci Sleep | 2022 | 36325277 | PubTator, text mining | PubMed |
| Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology. | Medicine (Baltimore) | 2022 | 36316840 | PubTator, text mining | PubMed |
| Identification of MRAP protein family as broad-spectrum GPCR modulators. | Clin Transl Med | 2022 | 36314066 | PubTator, text mining | PubMed |
| Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma. | Cancers (Basel) | 2022 | 36291758 | PubTator, text mining | PubMed |
| GPCRs in Intracellular Compartments: New Targets for Drug Discovery. | Biomolecules | 2022 | 36291552 | PubTator, text mining | PubMed |
RNA Sequencing of Intestinal Enterocytes Pre- and Post-Roux-en-Y Gastric Bypass Reveals Alteration in Gene Expression Related to Enterocyte Differentiation, Restitution, and Obesity with Regulation by Schlafen 12. | Cells | 2022 | 36291149 | PubTator, text mining | PubMed |
| Siglec-15 as a New Perspective Therapy Target in Human Giant Cell Tumor of Bone. | Curr Oncol | 2022 | 36290882 | PubTator, text mining | PubMed |
| Cellular Models of Alpha-Synuclein Aggregation: What Have We Learned and Implications for Future Study. | Biomedicines | 2022 | 36289910 | PubTator, text mining | PubMed |
| Astrocytes in the initiation and progression of epilepsy. | Nat Rev Neurol | 2022 | 36280704 | PubTator, text mining | PubMed |
| The ADORA1 mutation linked to early-onset Parkinson's disease alters adenosine A1-A2A receptor heteromer formation and function. | Biomed Pharmacother | 2022 | 36279718 | PubTator, text mining | PubMed |
| A Chemical Biological Approach to Study G Protein-Coupled Receptors: Labeling the Adenosine A1 Receptor Using an Electrophilic Covalent Probe. | ACS Chem Biol | 2022 | 36279267 | PubTator, text mining | PubMed |
| Novel active compounds and the anti-diabetic mechanism of mulberry leaves. | Front Pharmacol | 2022 | 36278175 | PubTator, text mining | PubMed |
| Discovery and Structure-Activity Relationship Studies of Novel Adenosine A1 Receptor-Selective Agonists. | J Med Chem | 2022 | 36270633 | PubTator, text mining | PubMed |
| Study on the mechanism of anti-acute lung injury of Shuanghuanglian oral liquid based on identification of transitional components in blood and network pharmacology. | J Chromatogr B Analyt Technol Biomed Life Sci | 2022 | 36265206 | PubTator, text mining | PubMed |
| Network pharmacology study on the potential effect mechanism of Chuanzhi Tongluo Capsule in the treatment of cerebral infarction. | Medicine (Baltimore) | 2022 | 36254030 | PubTator, text mining | PubMed |
| No evidence for intervention-associated DNA methylation changes in monocytes of patients with posttraumatic stress disorder. | Sci Rep | 2022 | 36253434 | PubTator, text mining | PubMed |
| Selective reduction of neurotransmitter release by cAMP-dependent pathways in mouse detrusor. | Am J Physiol Regul Integr Comp Physiol | 2022 | 36250635 | PubTator, text mining | PubMed |
| Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients. | Front Immunol | 2022 | 36248842 | PubTator, text mining | PubMed |
| Treating GNAO1 mutation-related severe movement disorders with oxcarbazepine: a case report. | Transl Pediatr | 2022 | 36247896 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/134/papers?page=16